Pricing Log in Create free account
Friday 6 November 2026 Export EXEL’s income statement to Excel — free account

Exelixis, Inc.

EXEL Healthcare Biotechnology

Exelixis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.98% from fiscal 2024.

Revenue
+10.2%
EPS
+22.2%
Free cash flow
−4.83%

Quarter to September 2026, against a year earlier

70.09 1.38 +2.01%
Market cap
$16.8B
P/E
19.9×
Fwd P/E
20.2×
Dividend yield
—
F-score
7/9
Altman Z
12.68
Beneish M
−2.61
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Exelixis, Inc. (EXEL) Current ratio

Alert me on Current ratio

Exelixis, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.2×, down 0.3× from fiscal 2025 (3.6×). Over the past ten years it has ranged from 1.7× (fiscal 2016) to 8.5× (fiscal 2018); the current reading is higher than 36% of that period. That is below the Biotechnology industry median of 4.9× and in line with the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 3.6× (2.11%)
FY2024 3.6× 8.74%
FY2023 3.3× (33.02%)
FY2022 5.0× (8.17%)
FY2021 5.4× (23.05%)
FY2020 7.1× (0.30%)
FY2019 7.1× (16.71%)
FY2018 8.5× 102.01%
FY2017 4.2× 141.28%
FY2016 1.7× (48.97%)

Quarterly newest first

Period Current ratio Change
Sep 2026 3.2× (7.15%)
Jun 2026 3.5× 6.08%
Mar 2026 3.3× (8.43%)
Dec 2025 3.6× (5.16%)
43 more quarters

Against its own ten years

Low 1.7× High 8.5×
Ten-year median 4.2×
Current reading's percentile 36

Current ratio against peers

Company Current ratio
BNTX BioNTech SE Sponsored ADR compare 8.6×
SMMT Summit Therapeutics PLC compare 7.0×
HALO Halozyme Therapeutics, Inc. compare 3.9×
EXEL Exelixis, Inc. 3.2×
ASND Ascendis Pharma A/S compare 3.0×
INSM Insmed, Inc. compare 2.9×
ALNY Alnylam Pharmaceuticals, Inc. compare 2.5×
BBIO BridgeBio Pharma, Inc. compare 2.1×
JAZZ Jazz Pharmaceuticals PLC compare 1.8×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on EXEL